Grifols, S.A. (NASDAQ:GRFS) Given Buy Rating at Bank of America Corporation

Grifols, S.A. (NASDAQ:GRFS)‘s stock had its “buy” rating reissued by investment analysts at Bank of America Corporation in a report issued on Tuesday, July 4th, StockTargetPrices.com reports.

Several other equities research analysts also recently commented on the stock. HSBC Holdings plc downgraded shares of Grifols, from a “hold” rating to a “reduce” rating in a research report on Friday, April 7th. Zacks Investment Research downgraded shares of Grifols, from a “buy” rating to a “hold” rating in a research report on Friday, May 5th. Goldman Sachs Group, Inc. (The) downgraded shares of Grifols, from a “buy” rating to a “neutral” rating in a research report on Friday, June 30th. J P Morgan Chase & Co upgraded shares of Grifols, from a “neutral” rating to an “overweight” rating in a research report on Thursday, March 30th. Finally, BidaskClub downgraded shares of Grifols, from a “buy” rating to a “hold” rating in a research report on Friday, June 9th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company’s stock. Grifols, has a consensus rating of “Hold” and an average target price of $24.00.

Shares of Grifols, (GRFS) opened at 20.46 on Tuesday. Grifols, has a 52 week low of $14.27 and a 52 week high of $22.83. The firm’s 50-day moving average is $21.04 and its 200 day moving average is $19.45. The company has a market capitalization of $27.41 billion, a PE ratio of 42.98 and a beta of 0.98.

ILLEGAL ACTIVITY NOTICE: “Grifols, S.A. (NASDAQ:GRFS) Given Buy Rating at Bank of America Corporation” was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://www.chaffeybreeze.com/2017/07/30/grifols-s-a-nasdaqgrfs-stock-rating-reaffirmed-by-bank-of-america-corporation-updated-updated-updated.html.

Hedge funds have recently bought and sold shares of the company. AKO Capital LLP purchased a new stake in Grifols, during the first quarter valued at about $36,979,000. Vaughan Nelson Investment Management L.P. purchased a new stake in Grifols, during the second quarter valued at about $57,845,000. FMR LLC raised its stake in Grifols, by 52.6% in the first quarter. FMR LLC now owns 6,352,581 shares of the biotechnology company’s stock valued at $119,905,000 after buying an additional 2,189,431 shares during the last quarter. NGAM Advisors L.P. raised its stake in Grifols, by 661.8% in the second quarter. NGAM Advisors L.P. now owns 632,072 shares of the biotechnology company’s stock valued at $13,356,000 after buying an additional 549,097 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in Grifols, by 25.1% in the first quarter. JPMorgan Chase & Co. now owns 1,926,442 shares of the biotechnology company’s stock valued at $36,362,000 after buying an additional 385,998 shares during the last quarter. Hedge funds and other institutional investors own 22.51% of the company’s stock.

Stock Target Prices

Receive News & Ratings for Grifols S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grifols S.A. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply